Tap "LegalTips"

to follow us

You may also feel interested in:Weekly Legal Update-Investigation into Alibaba LaunchedInternet Giant Companies fined for Violating Anti-Monopoly LawPublic Holiday Arrangement for 2021

On 31 Dec 2020, China has granted conditional market approval for its first COVID-19 vaccine, paving the way for mass immunization for thorough epidemic control and prevention.
20201231
The inactivated vaccine, developed by State-owned Sinopharm, which was approved on Wednesday night, is safe and has a 79.34 percent efficacy, based on data from the ongoing phase 3 clinical trial, Chen Shifei, deputy commissioner of the National Medical Products Administration, the top drug regulator, said at a news conference at the State Council Information Office.79.34%
Although the administration conducted strict inspection and evaluations using international standards before granting the approval, it will continue to carry out strict supervision over the product and its producer after market approval to ensure the phase 3 trial is completed according to standards, he said.
Prior to the conditional approval by the administration, the vaccine had already gained approval for general use in the United Arab Emirates on 9 Dec 2020 and in Bahrain on 13 Dec 2020. The large-scale phase 3 trial of the vaccine has involved more than 60,000 participants of 125 nationalities, according to Sinopharm.2020129202012131256
"Following the conditional approval today, and in particular, with the gradual increase in the production capacity of vaccines, we will promote vaccination among groups more vulnerable to COVID-19 such as the elderly and those with other medical conditions, and then a universal vaccination will follow," Zeng Yixin, vice-minister of the National Health Commission said, adding the vaccines will be provided to all people in China at no cost.""
"An immunity barrier will be established among the whole population to cut off transmission of the novel coronavirus, so the epidemic can be thoroughly contained in China."""


Tap "Read More" to visit our website

\n

Hot off the Press! Free COVID-19 Vaccines to All People in China

Tap "LegalTips"

to follow us

You may also feel interested in:Weekly Legal Update-Investigation into Alibaba LaunchedInternet Giant Companies fined for Violating Anti-Monopoly LawPublic Holiday Arrangement for 2021

On 31 Dec 2020, China has granted conditional market approval for its first COVID-19 vaccine, paving the way for mass immunization for thorough epidemic control and prevention.
20201231
The inactivated vaccine, developed by State-owned Sinopharm, which was approved on Wednesday night, is safe and has a 79.34 percent efficacy, based on data from the ongoing phase 3 clinical trial, Chen Shifei, deputy commissioner of the National Medical Products Administration, the top drug regulator, said at a news conference at the State Council Information Office.79.34%
Although the administration conducted strict inspection and evaluations using international standards before granting the approval, it will continue to carry out strict supervision over the product and its producer after market approval to ensure the phase 3 trial is completed according to standards, he said.
Prior to the conditional approval by the administration, the vaccine had already gained approval for general use in the United Arab Emirates on 9 Dec 2020 and in Bahrain on 13 Dec 2020. The large-scale phase 3 trial of the vaccine has involved more than 60,000 participants of 125 nationalities, according to Sinopharm.2020129202012131256
"Following the conditional approval today, and in particular, with the gradual increase in the production capacity of vaccines, we will promote vaccination among groups more vulnerable to COVID-19 such as the elderly and those with other medical conditions, and then a universal vaccination will follow," Zeng Yixin, vice-minister of the National Health Commission said, adding the vaccines will be provided to all people in China at no cost.""
"An immunity barrier will be established among the whole population to cut off transmission of the novel coronavirus, so the epidemic can be thoroughly contained in China."""


Tap "Read More" to visit our website

\n

No comments:

Post a Comment